4.7 Article

Design, synthesis, and SAR study of novel flavone 1,2,4-oxadiazole derivatives with anti-inflammatory activities for the treatment of Parkinson's disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Medicinal

Hybrids of delavirdine and piperdin-4-yl-aminopyrimidines (DPAPYs) as potent HIV-1 NNRTIs: Design, synthesis and biological activities

Wei Ming et al.

Summary: The hybrids of delavirdine and piperdin-4-yl-aminopyrimidine (DPAPYs) were synthesized and evaluated for their anti-HIV activities and inhibitory activities against HIV-1 reverse transcriptase. The results showed that all the compounds demonstrated moderate to excellent potency against wild-type HIV-1 and specific RT inhibitory activity. Compound 4d exhibited the most potent activity against wild-type HIV-1 and showed good to excellent potency against various HIV-1 mutants.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Review Cell Biology

Diabetes mellitus and Parkinson's disease: dangerous liaisons between insulin and dopamine

Angela De Iuliis et al.

Summary: This review reevaluates the dangerous liaison between diabetes mellitus and Parkinson's disease, highlighting the possible functional link between insulin and dopamine.

NEURAL REGENERATION RESEARCH (2022)

Article Chemistry, Medicinal

Improving the treatment of Parkinson's disease: Structure-based development of novel 5-HT2A receptor antagonists/inverse agonists

Mingxu Ma et al.

Summary: Based on the docking study of Pimavanserin, a series of novel Pimavanserin derivatives were designed and synthesized. Compound 7-16 exhibited significantly higher 5-HT2A receptor antagonist and inverse agonist activities than Pimavanserin, along with improved pharmacokinetics and safety profile.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Discovery of benzimidazole substituted 1, 2, 4-oxadiazole compounds as novel anti-HBV agents with TLR8-agonistic activities

Jingying Qiu et al.

Summary: In this study, a new series of compounds were designed as immunomodulatory anti-HBV agents. Compound 11o exhibited significant in vitro anti-HBV activity and promoted the secretion of cytokines, making it a potential immunomodulatory anti-HBV agent.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Discovery of small-molecule compounds and natural products against Parkinson's disease: Pathological mechanism and structural modification

Zhichao Zhong et al.

Summary: This review comprehensively summarizes the detailed pathological mechanisms and potential drugable targets of Parkinson's disease (PD), and provides information on approved, clinically tested, and drug discovery phase compounds related to PD.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Clinical Neurology

Management of Parkinson's disease and other movement disorders in women of childbearing age: Part 2

R. Garcia-Ramos et al.

Summary: The study aims to define the clinical characteristics of hyperkinetic movement disorders in women of childbearing age and establish guidelines for pregnancy and breastfeeding management. The results were developed through an exhaustive literature search and discussion by a group of movement disorder experts.

NEUROLOGIA (2021)

Review Biochemistry & Molecular Biology

Synthetic approaches to unsymmetrical 2,5-disubstituted 1,3,4-oxadiazoles and their MAO-B inhibitory activity. A review

Valentin Karabelyov et al.

Summary: Selective monoamine oxidase type B (MAO-B) inhibitors are used as adjuvants for treating early motor symptoms of Parkinson's disease. Recent research has focused on updating and summarizing inhibitors with oxadiazole scaffolds to explore more possibilities for compound design and ensure their safe use.

BIOORGANIC & MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives as novel GSK-3β inhibitors and evaluation of their potential as multifunctional anti-Alzheimer agents

Min Wang et al.

Summary: The study focused on the design and synthesis of novel compounds with multitarget-directed ligand-based strategy for Alzheimer's disease. Compound 10b demonstrated excellent potency in GSK-3 beta inhibition, anti-neuroinflammatory effects, and glucose consumption, as well as neuroprotective properties. In vivo experiments showed that compound 10b improved cognitive impairment in mouse models, indicating its potential as a multifunctional lead compound.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Design, synthesis, and SAR study of novel 4,5-dihydropyrazole-Thiazole derivatives with anti-inflammatory activities for the treatment of sepsis

Zhen Zhang et al.

Summary: In this study, a novel compound E26 was designed and synthesized to treat sepsis by inhibiting inflammatory response. Experimental results demonstrated that compound E26 exhibited potent anti-inflammatory activity by suppressing the production of various inflammatory factors through blocking the MAPKs signaling pathway, and showed significant efficacy in a mouse model of sepsis.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Structure-based screening for the discovery of 1,2,4-oxadiazoles as promising hits for the development of new anti-inflammatory agents interfering with eicosanoid biosynthesis pathways

Marianna Potenza et al.

Summary: This study identified three 1,2,4-oxadiazole compounds as potential multi-target inhibitors in the treatment of inflammatory disorders, with compound 5 showing promising results in in vivo experiments. The results suggest the potential for developing novel anti-inflammatory agents with a favorable pharmacological profile by expanding chemical diversity around the 1,2,4-oxadiazole central core.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Development and optimization of halogenated vinyl sulfones as Nrf2 activators for the treatment of Parkinson's disease

Ji Won Choi et al.

Summary: The synthesized compound 9d showed superior Nrf2 activation efficacy, significantly affecting Nrf2 nuclear translocation and protein levels in microglial BV-2 cells, inducing the expression of antioxidant response genes, and reducing the expression of proinflammatory cytokines and enzymes.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Discovery of Novel Pterostilbene Derivatives That Might Treat Sepsis by Attenuating Oxidative Stress and Inflammation through Modulation of MAPKs/NF-κB Signaling Pathways

Mengyuan Fang et al.

Summary: The researchers have developed a new derivative of pterostilbene, PIF_9, which shows anti-inflammatory and anti-oxidative activities for sepsis treatment. It acts by suppressing the NF-kappa B and MAPKs signaling pathways to alleviate inflammation and oxidative stress, demonstrating significant effects in mouse models.

ANTIOXIDANTS (2021)

Review Cell Biology

Oxidative stress factors in Parkinson's disease

Jolanta Dorszewska et al.

Summary: Parkinson's disease (PD) is the second most common cause of neurodegeneration, with oxidative stress leading to dopaminergic neuron degeneration. Mutations in genes such as SNCA, PRKN, PINK1, DJ1, and LRRK2 are associated with disrupted oxidoreductive homeostasis in PD. Treatment options for PD include optimizing dopaminergic therapy and introducing advanced therapies such as deep brain stimulation, with genetic factors playing a role in response to treatment.

NEURAL REGENERATION RESEARCH (2021)

Review Immunology

Regulation of immune-driven pathogenesis in Parkinson's disease by gut microbiota

Wenxia Zheng et al.

BRAIN BEHAVIOR AND IMMUNITY (2020)

Article Environmental Sciences

The USA lags behind other agricultural nations in banning harmful pesticides

Nathan Donley

ENVIRONMENTAL HEALTH (2019)

Article Biochemistry & Molecular Biology

Synthesis and in vitro and in vivo anti-inflammatory activity of novel 4-ferrocenylchroman-2-one derivatives

Wei-Yun Guo et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)

Review Chemistry, Medicinal

Recent advance in oxazole-based medicinal chemistry

Hui-Zhen Zhang et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Biochemistry & Molecular Biology

Resveratrol-based cinnamic ester hybrids: synthesis, characterization, and anti-inflammatory activity

Ban-Feng Ruan et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)

Article Biochemistry & Molecular Biology

Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation

Bozena Kaminska et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)

Review Chemistry, Medicinal

Flavones: An important scaffold for medicinal chemistry

Manjinder Singh et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)

Article Neurosciences

Parkinson's disease cognitive network correlates with caudate dopamine

Martin Niethammer et al.

NEUROIMAGE (2013)

Article Clinical Neurology

Meta-Analysis of Early Nonmotor Features and Risk Factors for Parkinson Disease

Alastair J. Noyce et al.

ANNALS OF NEUROLOGY (2012)

Review Pharmacology & Pharmacy

Macrophages and Tissue Injury: Agents of Defense or Destruction?

Debra L. Laskin et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)

Article Environmental Sciences

Rotenone, Paraquat, and Parkinson's Disease

Caroline M. Tanner et al.

ENVIRONMENTAL HEALTH PERSPECTIVES (2011)

Review Biochemistry & Molecular Biology

Mechanisms Underlying Inflammation in Neurodegeneration

Christopher K. Glass et al.

Article Chemistry, Medicinal

Convenient synthesis and biological profile of 5-amino-substituted 1,2,4-oxadiazole derivatives

Maria Ispikoudi et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)

Article Geriatrics & Gerontology

mRNA up-regulation of MHC II and pivotal pro-inflammatory genes in normal brain aging

MG Frank et al.

NEUROBIOLOGY OF AGING (2006)

Article Mechanics

A general solution of unsteady Stokes equations

A Venkatalaxmi et al.

FLUID DYNAMICS RESEARCH (2004)

Review Medicine, General & Internal

Parkinson's disease

A Samii et al.

LANCET (2004)